• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐药性高血压、继发性高血压和高血压危象:诊断评估与治疗。

Resistant hypertension, secondary hypertension, and hypertensive crises: diagnostic evaluation and treatment.

机构信息

Department of Medicine, University of Alabama at Birmingham, 35294-2041, USA.

出版信息

Cardiol Clin. 2010 Nov;28(4):639-54. doi: 10.1016/j.ccl.2010.07.002.

DOI:10.1016/j.ccl.2010.07.002
PMID:20937447
Abstract

Hypertension is a very common modifiable risk factor for cardiovascular morbidity and mortality. Patients with hypertension represent a diverse group. In addition to those with primary hypertension, there are patients whose hypertension is attributable to secondary causes, those with resistant hypertension, and patients who present with a hypertensive crisis. Secondary causes of hypertension account for less than 10% of cases of elevated blood pressure (BP), and screening for these causes is warranted if clinically indicated. Patients with resistant hypertension, whose BP remains uncontrolled in spite of use of 3 or more antihypertensive agents, are at increased cardiovascular risk compared with the general hypertensive population. After potentially correctible causes of uncontrolled BP (pseudoresistance, secondary causes, and intake of interfering substances) are eliminated, patients with true resistant hypertension are managed by encouraging therapeutic lifestyle changes and optimizing the antihypertensive regimen, whereby the clinician ensures that the medications are prescribed at optimal doses using drugs with complementary mechanisms of action, while adding an appropriate diuretic if there are no contraindications. Mineralocorticoid receptor antagonists are formidable add-on agents to the antihypertensive regimen, usually as a fourth drug, and are effective in reducing BP even in patients without biochemical evidence of aldosterone excess. In the setting of a hypertensive crisis, the BP has to be reduced within hours in the case of a hypertensive emergency (elevated BP with evidence of target organ damage) using parenteral agents, and within a few days if there is hypertensive urgency, using oral antihypertensive agents.

摘要

高血压是心血管发病率和死亡率的一个非常常见的可改变危险因素。高血压患者是一个多样化的群体。除了原发性高血压患者,还有一些高血压是由继发性原因引起的,一些是难治性高血压患者,还有一些是高血压急症患者。继发性高血压占血压升高(BP)病例的比例不到 10%,如果临床需要,应进行这些原因的筛查。与一般高血压人群相比,血压控制不佳的难治性高血压患者(尽管使用了 3 种或更多种降压药物)发生心血管风险增加。在消除了未控制 BP 的潜在可纠正原因(假性抵抗、继发性原因和摄入干扰物质)后,通过鼓励治疗性生活方式改变和优化降压方案来管理真正的难治性高血压患者,在此过程中,临床医生确保以最佳剂量开具具有互补作用机制的药物,同时在没有禁忌症的情况下添加适当的利尿剂。盐皮质激素受体拮抗剂是降压方案的有力附加药物,通常作为第四种药物,即使在没有醛固酮过多生化证据的患者中,也能有效降低血压。在高血压急症的情况下,需要在数小时内使用静脉药物降低血压,对于高血压紧急情况(血压升高并伴有靶器官损伤证据);如果是高血压亚急症,需要在数天内使用口服降压药物降低血压。

相似文献

1
Resistant hypertension, secondary hypertension, and hypertensive crises: diagnostic evaluation and treatment.耐药性高血压、继发性高血压和高血压危象:诊断评估与治疗。
Cardiol Clin. 2010 Nov;28(4):639-54. doi: 10.1016/j.ccl.2010.07.002.
2
Reduction of blood pressure in patients with treatment-resistant hypertension.治疗抵抗性高血压患者的血压降低。
Expert Opin Pharmacother. 2009 Dec;10(18):2959-71. doi: 10.1517/14656560903379552.
3
The future of antihypertensive treatment.抗高血压治疗的未来。
Am J Ther. 2007 Mar-Apr;14(2):121-34. doi: 10.1097/01.pap.0000249915.12185.58.
4
Identifying and managing factors that interfere with or worsen blood pressure control.识别和管理干扰或加重血压控制的因素。
Postgrad Med. 2010 Mar;122(2):35-48. doi: 10.3810/pgm.2010.03.2120.
5
[District program to improve the cardiovascular risk of resistant hypertensive patients in general medicine].[普通内科改善难治性高血压患者心血管风险的区域项目]
Arch Mal Coeur Vaiss. 2005 Jul-Aug;98(7-8):761-6.
6
Current options for the treatment of resistant hypertension.难治性高血压的当前治疗选择。
Expert Rev Cardiovasc Ther. 2009 Nov;7(11):1385-93. doi: 10.1586/erc.09.120.
7
[Hypertensive emergency and urgence].[高血压急症与亚急症]
Herz. 2003 Dec;28(8):717-24. doi: 10.1007/s00059-003-2506-8.
8
The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.2004年加拿大高血压管理指南:第二部分——治疗
Can J Cardiol. 2004 Jan;20(1):41-54.
9
Resistant hypertension: an overview.难治性高血压:概述
Can J Cardiol. 1996 Sep;12(9):822-8.
10
Update on diagnosis and treatment of resistant hypertension.难治性高血压的诊断与治疗进展
Iran J Kidney Dis. 2011 Jul;5(4):215-27.

引用本文的文献

1
Malignant hypertension: current challenges, prevention strategies, and future perspectives.恶性高血压:当前挑战、预防策略及未来展望
Front Cardiovasc Med. 2024 Dec 24;11:1409212. doi: 10.3389/fcvm.2024.1409212. eCollection 2024.
2
Beyond Conventional Control: Insights Into Drug-Resistant Hypertension.超越传统控制:对耐药性高血压的见解
Cureus. 2023 Aug 17;15(8):e43617. doi: 10.7759/cureus.43617. eCollection 2023 Aug.
3
Nonadherence to Self-Care Practices, Antihypertensive Medications, and Associated Factors among Hypertensive Patients in a Follow-up Clinic at Asella Referral and Teaching Hospital, Ethiopia: A Cross-Sectional Study.
埃塞俄比亚阿塞拉转诊与教学医院随访门诊高血压患者的自我护理措施、抗高血压药物依从性及相关因素:一项横断面研究
Int J Hypertens. 2021 Oct 31;2021:7359318. doi: 10.1155/2021/7359318. eCollection 2021.
4
A Search for Secondary Hypertension: "Where's Waldo?".继发性高血压的筛查:“沃尔多在哪里?”
Cureus. 2021 Jun 16;13(6):e15698. doi: 10.7759/cureus.15698. eCollection 2021 Jun.
5
Effects of Caloric Restriction Diet on Arterial Hypertension and Endothelial Dysfunction.热量限制饮食对动脉高血压和血管内皮功能障碍的影响。
Nutrients. 2021 Jan 19;13(1):274. doi: 10.3390/nu13010274.
6
Prevalence and factors associated with uncontrolled hypertension among adult hypertensive patients on follow-up at Northern Ethiopia, 2019: cross-sectional study.2019 年,在埃塞俄比亚北部接受随访的成年高血压患者中,高血压未得到控制的患病率及其相关因素:横断面研究。
Pan Afr Med J. 2020 Jul 15;36:187. doi: 10.11604/pamj.2020.36.187.23312. eCollection 2020.
7
Magnetic stimulation of carotid sinus as a treatment for hypertension.颈动脉窦磁刺激治疗高血压。
J Clin Hypertens (Greenwich). 2019 Feb;21(2):299-306. doi: 10.1111/jch.13470. Epub 2019 Jan 13.
8
The management of hypertension in women planning for pregnancy.女性备孕人群的高血压管理。
Br Med Bull. 2018 Dec 1;128(1):75-84. doi: 10.1093/bmb/ldy035.
9
Mechanisms of isolevuglandin-protein adduct formation in inflammation and hypertension.炎症和高血压中异前列烷-蛋白质加合物形成的机制。
Prostaglandins Other Lipid Mediat. 2018 Nov;139:48-53. doi: 10.1016/j.prostaglandins.2018.09.008. Epub 2018 Sep 29.
10
Kidney protective effects of baroreflex activation therapy in patients with resistant hypertension.血管紧张素受体脑啡肽酶抑制剂在射血分数降低的心力衰竭患者中的应用:PARADIGM-HF 试验的事后分析
J Clin Hypertens (Greenwich). 2018 Oct;20(10):1519-1526. doi: 10.1111/jch.13365. Epub 2018 Sep 10.